SPOK HOLDINGS, INC. (SPOK) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b) Spok Holdings, Inc. (“the Company”) announced with great sadness today that Nicholas A. Gallopo, a valued and long-standing member of the Company’s Board of Directors, passed away on November 14, 2016, after a brief illness. The late Mr. Gallopo served as a director for the Company since 2004 over which time the Company benefited greatly under his leadership as Chairman of the Audit Committee. His distinguished financial career included time as a partner at Arthur Andersen LLP as well as director positions with Newman Drug Company, Wyant Corporation and Bridge Information Systems, Inc. The Board of Directors appreciates Mr. Gallopo’s invaluable contributions to the Company during his tenure of service and expresses the deepest condolences to his family and loved ones.
Mr. Matthew Oristano, a director of the Company and a member of the Audit Committee since November 16, 2004, is assuming the role of Chairman of the Audit Committee. Mr. Oristano qualifies as a “financial expert” as defined in Section 407(a) of the Sarbanes-Oxley Act of 2002, 15 U.S.C. 7265, and Nasdaq Rule 5605(c)(2)(A). In addition, Mr. Samme L. Thompson, a director of the Company, has been appointed Chairman of the Nominating and Governance Committee.
About SPOK HOLDINGS, INC. (SPOK)